Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate-Specific Membrane Antigen
One reagent for two techniques: Compound [111In]1 provides a platform for sequential radionuclide and optical imaging of prostate cancer through targeting of the prostate‐specific membrane antigen. Because the same subject can be dual‐imaged after one injection of the agent, these findings support r...
Saved in:
Published in: | Angewandte Chemie International Edition Vol. 50; no. 39; pp. 9167 - 9170 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Weinheim
WILEY-VCH Verlag
19-09-2011
WILEY‐VCH Verlag Wiley Subscription Services, Inc |
Edition: | International ed. in English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | One reagent for two techniques: Compound [111In]1 provides a platform for sequential radionuclide and optical imaging of prostate cancer through targeting of the prostate‐specific membrane antigen. Because the same subject can be dual‐imaged after one injection of the agent, these findings support rapid clinical translation. |
---|---|
Bibliography: | ark:/67375/WNG-FZJMDTKP-4 ArticleID:ANIE201102872 We thank Dr. David Wasserman of LI-COR Biosciences for use of their equipment and guidance in the in vivo study. We also thank U24 CA92871, R01 CA134675 and K25 CA148901 for financial support. SPECT=single photon emission computed tomography. K25 - No. CA148901 istex:A2C41C9F7D66A427B3586281176D9A786CBEFE90 U24 - No. CA92871 R01 - No. CA134675 We thank Dr. David Wasserman of LI‐COR Biosciences for use of their equipment and guidance in the in vivo study. We also thank U24 CA92871, R01 CA134675 and K25 CA148901 for financial support. SPECT=single photon emission computed tomography. |
ISSN: | 1433-7851 1521-3773 |
DOI: | 10.1002/anie.201102872 |